Earnings-backed filing view

AbbVie Inc. (ABBV)

See the latest ABBV earnings framing tied back to the filing, including recent revenue and EPS trend context.

Healthcare 10-K Next earnings Date not scheduled

AI filing summary

AbbVie Inc. earnings insights

The filing reads constructive based on revenue and statement momentum.

The latest 10-K for ABBV shows revenue was $61.2B and net income was $4.2B.

Key changes

What stands out in the latest report

  • Revenue moved to $61.2B from $56.3B (+8.6% vs prior).
  • Net income moved to $4.2B from $4.3B (-1.2% vs prior).
  • Diluted EPS moved to $2.36 from $2.39 (-1.3% vs prior).

Current read

Mixed-to-negative read

Financial snapshot

Latest reported figures

Revenue $61.2B
Net income $4.2B
EPS $2.36
Operating cash flow $19.0B

Trend section

Recent revenue trend

Q1 $13.3B

Period ended 2025-03-31

Q2 $15.4B

Period ended 2025-06-30

Q3 $15.8B

Period ended 2025-09-30

FY $16.6B

Period ended 2025-12-31

Trend section

Recent EPS trend

Q1 N/A

Filed period trend snapshot.

Q2 N/A

Filed period trend snapshot.

Q3 N/A

Filed period trend snapshot.

FY N/A

Filed period trend snapshot.

Related links

Move through the research workflow

Related companies

Read-throughs worth checking